Holds 2 active US DMFs for ospemifene, filing since 2016. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF for ospemifene, filing since 2021. Its GMP is recognised in 12 markets.
Holds one active US DMF for ospemifene, filing since 2011. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for ospemifene, filing since 2023. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for ospemifene, filing since 2015. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
Holds one active US DMF for ospemifene, filing since 2016. Its 2019 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one active US DMF for ospemifene, filing since 2016. Its 2024 FDA inspection closed as VAI.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for ospemifene and what filings they hold.
Chat with Fred, your AI analyst